National Drug Policy Board

This executive order establishes the National Drug Policy Board, chaired by the Attorney General with the Secretary of Health and Human Services as Vice Chairman, to coordinate all federal drug abuse policy functions across executive departments. It creates two coordinating groups for enforcement and prevention/health, and consolidates duties previously held by the National Drug Enforcement Policy Board.

52 FR 10021

No PDF available for this document.

Impact dates

Date TBD
Establishment of Drug Enforcement Coordinating Group and Drug Abuse Prevention and Health Coordinating Group

Key directives

Establish National Drug Policy Board with 17 designated members plus presidential appointees
Attorney General serves as Chairman; HHS Secretary as Vice Chairman
Board shall facilitate development and coordination of national drug policy
Board shall coordinate executive branch activities to reduce supply and use of illegal drugs
Board shall review, evaluate and develop policy, strategy, resources, and budgetary priorities
Board shall establish Drug Enforcement Coordinating Group
Board shall establish Drug Abuse Prevention and Health Coordinating Group
Chairman shall act as primary advisor to President and Congress on national and international drug programs
Board assumes all duties of National Drug Enforcement Policy Board under Public Law 98-473 Chapter XIII
Amends Executive Order 12368 (incorporated by reference)

Who is ordered

Timeline

Immediate

Board establishment and membership designation
Attorney General assumes chairmanship
Two coordinating groups to be established

Near term (90d)

Coordination mechanisms to be operational
Policy review and strategy development to begin
Intelligence correlation systems to be organized

Long term

Ongoing interagency coordination of drug policy
Integration of international enforcement with domestic prevention and treatment
Congressional advising on national and international drug programs

Risks & tensions

No explicit deadlines specified for coordinating group establishment—timing is discretionary
Large membership (17+ agencies) may create coordination challenges; text does not specify decision-making protocols beyond chairman role
Potential tension between enforcement-focused Attorney General chair and health/prevention vice chair reflects structural ambiguity in prioritization
OMB authorities explicitly preserved, suggesting budgetary control tensions were anticipated
Vague 'from time to time' language for additional presidential designations leaves membership fluid